Continuous analyte measurement systems and systems and methods for implanting them

Patent metadata

Field	Value
Publication number	US-12350042-B2
Application number	US-202217680053-A
Country	US
Kind code	B2
Filing date	Feb 24, 2022
Priority date	Jul 23, 2009
Publication date	Jul 8, 2025
Grant date	Jul 8, 2025

Abstract

Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.

First claim

What is claimed is:

1. A glucose monitoring system, comprising:
a data processing unit configured to be mounted on a skin surface and comprising:
a processor,
a transmitter, and
one or more memories communicatively coupled with the processor; and

a glucose sensor comprising a proximal portion configured to be electrically coupled to the processor of the data processing unit and a distal portion configured to be inserted through the skin surface and in contact with a bodily fluid, wherein the glucose sensor is configured to generate electrical signals indicative of levels of glucose in the bodily fluid, wherein the distal portion comprises:
a plurality of electrodes comprising a working electrode,
a glucose responsive enzyme layer on the working electrode, and
a first membrane layer on the glucose responsive enzyme layer configured to modulate a flux of glucose to the glucose responsive enzyme layer,

wherein the glucose sensor is configured to provide for perpendicular and lateral diffusion of glucose through the first membrane layer to the glucose responsive enzyme layer, and
wherein a sensor specific calibration parameter for the glucose sensor is stored in the one or more memories, the sensor specific calibration parameter having been determined based in part on:
testing a glucose response of a sample of a plurality of glucose sensors to determine a representative calibration parameter of the plurality of glucose sensors, wherein the sample of the plurality of glucose sensors does not include the glucose sensor;
non-destructively determining a characteristic of the glucose sensor; and
calculating the sensor specific calibration parameter by adjusting the representative calibration parameter of the plurality of glucose sensors based upon at least the characteristic of the glucose sensor and a representative characteristic of the plurality of glucose sensors;

wherein the data processing unit is configured to use the sensor specific calibration parameter to generate calibrated levels of glucose; and
wherein the glucose sensor does not require calibration using a reference value during in vivo use of the glucose sensor, the in vivo use of the glucose sensor lasting between 3 and 14 days.

2. The glucose monitoring system of claim 1 , wherein the distal portion further comprises a second membrane layer configured to reduce presence of interferents at the first membrane layer.

3. The glucose monitoring system of claim 1 , wherein the data processing unit is configured for perpendicular insertion of the glucose sensor through the skin surface.

4. The glucose monitoring system of claim 1 , further comprising a receiver unit in communication with the transmitter of the data processing unit, wherein the receiver unit is configured to receive communications from the data processing unit, including sensor data related to levels of glucose.

5. The glucose monitoring system of claim 4 , wherein the receiver unit is configured to generate the calibrated levels of glucose.

6. The glucose monitoring system of claim 4 , wherein the receiver unit is configured to provide one or more alarms to a user.

7. The glucose monitoring system of claim 6 , wherein the one or more alarms is related to a calibration status of the glucose sensor.

8. The glucose monitoring system of claim 6 , wherein the one or more alarms is related to a dislodgment of the glucose sensor.

9. The glucose monitoring system of claim 6 , wherein the one or more alarms is related to a malfunction of the glucose sensor.

10. The glucose monitoring system of claim 6 , wherein the one or more alarms is related to the levels of glucose approaching a threshold value.

11. The glucose monitoring system of claim 6 , wherein the one or more alarms is related to the levels of glucose reaching or exceeding a threshold value.

12. The glucose monitoring system of claim 4 , wherein the receiver unit is a first receiver unit, and the system comprises a second receiver unit.

13. The glucose monitoring system of claim 12 , wherein the second receiver unit is a wristwatch.

14. The glucose monitoring system of claim 1 , wherein the distal portion comprises three electrodes.

15. The glucose monitoring system of claim 1 , wherein the data processing unit comprises an adhesive bottom for adhering to the skin surface.

16. The glucose monitoring system of claim 1 , wherein the data processing unit comprises a connection portion from which the distal portion of the glucose sensor is configured to extend for insertion through the skin surface.

17. The glucose monitoring system of claim 1 , wherein the glucose sensor is a wire sensor.

18. The glucose monitoring system of claim 1 , wherein the glucose monitoring system is configured to determine the levels of glucose using a drift correction factor.

19. The glucose monitoring system of claim 1 , wherein the sensor specific calibration parameter comprises a sensor sensitivity.

20. The glucose monitoring system of claim 1 , wherein the determined characteristic comprises at least one of: a thickness of the first membrane layer; a surface area of an active sensing area of the glucose responsive layer; and a volume of an active sensing area of the glucose responsive layer.

21. The glucose monitoring system of claim 1 , wherein the determined characteristic is determined using an optical scanner.

22. The glucose monitoring system of claim 1 , wherein testing the glucose response of the sample of the plurality of glucose sensors comprises performing an in vitro test.

23. The glucose monitoring system of claim 1 ,
wherein the sensor specific calibration parameter is further determined based in part on:
determining the representative characteristic of the plurality of glucose sensors;
comparing the characteristic of the glucose sensor to the representative characteristic of the plurality of glucose sensors to determine a correction factor; and
adjusting the calibration parameter of the plurality of glucose sensors using the correction factor.

24. The glucose monitoring system of claim 23 , wherein the representative calibration parameter of the plurality of glucose sensors is a mean sensitivity of the plurality of glucose sensors and the sensor specific calibration parameter is a sensor specific sensitivity.

25. The glucose monitoring system of claim 1 , wherein the glucose sensor comprises a first functional side and a second functional side, and
wherein data processing unit further comprises a conductive member in electrical contact with the first functional side and the second functional side.

26. A method for determining a calibration parameter for a glucose sensor, the method comprising:
providing a plurality of glucose sensors, each glucose sensor comprising:
a proximal portion configured to be electrically coupled to a processor of a data processing unit, and
a distal portion configured to be inserted through a skin surface and in contact with a bodily fluid, wherein the glucose sensor is configured to generate electrical signals indicative of levels of glucose in the bodily fluid, wherein the distal portion comprises:
a plurality of electrodes comprising a working electrode,
a glucose responsive enzyme layer on the working electrode, and
a first membrane layer on the glucose responsive enzyme layer configured to modulate a flux of glucose to the glucose responsive enzyme layer,
wherein the glucos

Assignees

• Abbott Diabetes Care Inc

Inventors

• Hoss Udo
• Mazza John Charles
• Le Phu
• Thomas Christopher A
• Mcgarraugh Geoffrey V
• Hayter Gary Alan

Classifications

• A61B2560/0443

  Modular apparatus · CPC title

• A61B5/7221

  Determining signal validity, reliability or quality (preventing, reducing or removing noise induced by motion artefacts A61B5/7207; noise originating from a therapeutic or surgical apparatus A61B5/7217) · CPC title

• A61B5/6833

  Adhesive patches · CPC title

• A61B5/002

  Monitoring the patient using a local or closed circuit, e.g. in a room or building (A61B5/0017 takes precedence) · CPC title

• A61B2562/227

  Sensors with electrical connectors · CPC title